In the liver, dual ARID1A/B loss leads to similar aggressiveness and enhanced dedifferentiation coupled with impaired liver function46; based on our mechanistic findings, FHD-286 alone or in combination with chemotherapy may thus warrant clinical investigation in these cancers. The gene discussed is ARID1A; the disease is cancer.